Downregulation of ornithine decarboxylase by pcDNA-ODCr inhibits gastric cancer cell growth in vitro
暂无分享,去创建一个
Xian-xi Liu | W. Wang | B. Liu | Chun-xiao Xu | Chun-ying Jiang | Yun-Fei Yan | Shi-min Chen | Ya-pei Yang | J. Xin | Z. Lu | Xian‐xi Liu
[1] Benyan Wu,et al. Impact of BTG2 expression on proliferation and invasion of gastric cancer cells in vitro , 2010, Molecular Biology Reports.
[2] Mei Zhao,et al. Overexpression of PIP5KL1 suppresses cell proliferation and migration in human gastric cancer cells , 2010, Molecular Biology Reports.
[3] Zhongdong Chen,et al. Association of Cytotoxic T Lymphocyte-associated antigen-4 gene haplotype with the susceptibility to gastric cancer , 2009, Molecular Biology Reports.
[4] R. Zhou,et al. Association of functional polymorphisms in MMPs genes with gastric cardia adenocarcinoma and esophageal squamous cell carcinoma in high incidence region of North China , 2009, Molecular Biology Reports.
[5] Jian-ming Fan,et al. Induced apoptotic action of recombinant trichosanthin in human stomach adenocarcinoma MCG803 cells , 2009, Molecular Biology Reports.
[6] Yumin Li,et al. PARP-1 Val762Ala polymorphism, CagA+H. pylori infection and risk for gastric cancer in Han Chinese population , 2009, Molecular Biology Reports.
[7] M. Saadat,et al. Genetic polymorphisms of GSTO2, GSTM1, and GSTT1 and risk of gastric cancer , 2009, Molecular Biology Reports.
[8] W. Guo,et al. An investigation on the polymorphisms of two DNA repair genes and susceptibility to ESCC and GCA of high-incidence region in northern China , 2009, Molecular Biology Reports.
[9] Jian-sheng Li,et al. Expression of ornithine decarboxylase in precancerous and cancerous gastric lesions. , 2007, World journal of gastroenterology.
[10] H. Tian,et al. Gene expression of ornithine decarboxylase in lung cancers and its clinical significance. , 2006, Acta biochimica et biophysica Sinica.
[11] Xianrang Song,et al. Lentiviral Vector-Mediated Downregulation of Ornithine Decarboxylase Inhibits Tumor Cell Growth in vitro and in vivo , 2006, Tumor Biology.
[12] H. Tian,et al. Antitumor effect of antisense ornithine decarboxylase adenovirus on human lung cancer cells. , 2006, Acta biochimica et biophysica Sinica.
[13] L. Young,et al. Ornithine Decarboxylase (ODC) Expression Pattern in Human Prostate Tissues and ODC Transgenic Mice , 2006, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[14] S. Spechler,et al. Concepts in the Prevention of Adenocarcinoma of the Distal Esophagus and Proximal Stomach , 2005, CA: a cancer journal for clinicians.
[15] L. Gong,et al. Antitumor effect of antisense ODC adenovirus on human prostate cancer cells , 2005, Prostate Cancer and Prostatic Diseases.
[16] Gong Lei. The screening of the sensitive antisense target in the ODCmRNA , 2005 .
[17] Bingzhang,et al. Ornithine decarboxylase gene is overexpressed in colorectal carcinoma , 2005 .
[18] A. Ootani,et al. Decreased apoptosis and increased ornithine decarboxylase activity in the intestinal mucosa of rats with bilateral ventromedial hypothalamus lesions , 2005, Journal of Gastroenterology.
[19] J. Testa,et al. Loss of Methylthioadenosine Phosphorylase and Elevated Ornithine Decarboxylase Is Common in Pancreatic Cancer , 2004, Clinical Cancer Research.
[20] R. Love,et al. Ornithine Decarboxylase (ODC) as a Prognostic Factor in Operable Breast Cancer , 2003, Breast Cancer Research and Treatment.
[21] D. Alberts,et al. Pronounced reduction in adenoma recurrence associated with aspirin use and a polymorphism in the ornithine decarboxylase gene , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[22] C. Kahana,et al. Ornithine decarboxylase-antizyme is rapidly degraded through a mechanism that requires functional ubiquitin-dependent proteolytic activity. , 2002, European journal of biochemistry.
[23] W. Paschen,et al. Polyamine metabolism in brain tumours: diagnostic relevance of quantitative biochemistry , 2001, Journal of neurology, neurosurgery, and psychiatry.
[24] P. Coffino. Ubiquitin and proteasomes: Regulation of cellular polyamines by antizyme , 2001, Nature Reviews Molecular Cell Biology.
[25] T. Langer,et al. Molecular correlates of the action of bis(ethyl)polyamines in breast cancer cell growth inhibition and apoptosis. , 2000, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[26] J. Díaz,et al. Prognostic value of ornithine decarboxylase and polyamines in human breast cancer: correlation with clinicopathologic parameters. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[27] T. Patel,et al. Polyamine depletion arrests cell cycle and induces inhibitors p21(Waf1/Cip1), p27(Kip1), and p53 in IEC-6 cells. , 1999, The American journal of physiology.
[28] K. Mimori,et al. Expression of ornithine decarboxylase mRNA and c-myc mRNA in breast tumours. , 1998, International journal of oncology.
[29] L. Andersson,et al. Human ornithine decarboxylase-overproducing NIH3T3 cells induce rapidly growing, highly vascularized tumors in nude mice. , 1997, Cancer research.
[30] H. Kiyosawa,et al. Ornithine decarboxylase overexpression in mouse 10T1/2 fibroblasts: cellular transformation and invasion. , 1997, Journal of the National Cancer Institute.
[31] K Sugimachi,et al. Expression of ornithine decarboxylase mRNA in gastric carcinoma , 1996, Cancer.
[32] J. Ajani,et al. Preoperative infusional chemoradiation therapy for stage T3 rectal cancer. , 1995, International journal of radiation oncology, biology, physics.
[33] T. Rich. Adjuvant radiotherapy for rectal cancer: more on pre- or postoperative therapy. , 1995, International journal of radiation oncology, biology, physics.
[34] L. Marton,et al. Polyamines as targets for therapeutic intervention. , 1995, Annual review of pharmacology and toxicology.
[35] J A Moshier,et al. Transformation of NIH/3T3 cells by ornithine decarboxylase overexpression. , 1993, Cancer research.
[36] L. Andersson,et al. Ornithine decarboxylase activity is critical for cell transformation , 1992, Nature.
[37] J. Murat,et al. Involvement of ornithine decarboxylase in the control of proliferation of the HT29 human colon cancer cell line. effect of vasoactive intestinal peptide on enzyme activity , 1991, International journal of cancer.
[38] P. Coffino,et al. Killer polyamines? , 1991, Journal of cellular biochemistry.
[39] H. Lehväslaiho,et al. Activation of the neu tyrosine kinase induces the fos/jun transcription factor complex, the glucose transporter and ornithine decarboxylase , 1989, The Journal of cell biology.
[40] R. Madhubala,et al. Control of ornithine decarboxylase activity in alpha-difluoromethylornithine-resistant L1210 cells by polyamines and synthetic analogues. , 1988, The Journal of biological chemistry.
[41] K. Alitalo,et al. The mechanisms of ornithine decarboxylase deregulation in c-Ha-ras oncogene-transformed NIH 3T3 cells. , 1988, The Journal of biological chemistry.
[42] T. Thomas,et al. Additive growth-inhibitory effects of DL-alpha-difluoromethylornithine and antiestrogens on MCF-7 breast cancer cell line. , 1987, Biochemical and biophysical research communications.
[43] P. McCann,et al. Inhibition of polyamine metabolism : biological significance and basis for new therapies , 1987 .